Kiniksa Pharmaceuticals International (KNSA) P/E (2021 - 2026)
Kiniksa Pharmaceuticals International (KNSA) P/E from Mar 31, 2021 to Jun 3, 2026. The TTM Kiniksa Pharmaceuticals International (KNSA) P/E is 53.03. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Kiniksa Pharmaceuticals International (KNSA)
| Year | P/E | Change |
|---|---|---|
| 2026 | 53.03 | -44.70% |
| 2025 | 95.91 | -429.68% |
| 2024 | -29.09 | -608.82% |
| 2023 | 5.72 | -18.74% |
| 2022 | 7.04 | -206.24% |
| 2021 | -6.62 | N/A |
Comparison Kiniksa Pharmaceuticals International (KNSA) P/E with competitors
Kiniksa Pharmaceuticals International (KNSA) P/E is 53.03.